Celularity Inc Quick Ratio (CELU) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Celularity Inc   (NASDAQ: CELU)

Celularity Inc 's Quick Ratio

CELU's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Celularity Inc 's Cash & cash equivalent grew by 5045.83 % in the Q4 2025 sequentially, faster than Current Liabilities, this led to improvement in Celularity Inc 's Quick Ratio to 0.08, Quick Ratio remained below Celularity Inc average.

Within Major Pharmaceutical Preparations industry 477 other companies have achieved higher Quick Ratio than Celularity Inc in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from 3715 to 4431.

Explain Quick Ratio?
How much Cash & cash equivalents CELU´s has?
What are CELU´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELU Quick Ratio (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2		 (Mar 31 2025)
Q1		 (Dec 31 2024)
Q4
Y / Y Current Liabilities Change 45.88 % -14.25 % 1.95 % -11.14 % -38.72 %
Y / Y Cash & cash equivalent Change 736.72 % -9.77 % 84.8 % -84.6 % 225.11 %
Quick Ratio MRQ 0.08 0 0.01 0 0.01
CELU's Total Ranking # 4431 # 3715 # 3638 # 3668 # 4366
Seq. Current Liabilities Change 23.65 % -5.65 % 17.95 % 6.02 % -27.32 %
Seq. Cash & cash equivalent Change 5045.83 % -86.1 % 194.54 % -60.3 % 454.89 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 478
Healthcare Sector # 962
Overall Market # 4431


Quick Ratio Statistics
High Average Low
41.17 2.89 0
(Dec 31 2018)   (Jun 30 2021)




Financial Statements
Celularity Inc 's Current Liabilities $ 81 Millions Visit CELU's Balance sheet
Celularity Inc 's Cash & cash equivalent $ 6 Millions Visit CELU's Balance sheet
Source of CELU's Sales Visit CELU's Sales by Geography


Cumulative Celularity Inc 's Quick Ratio

CELU's Quick Ratio for the trailling 12 Months

CELU Quick Ratio

 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months		 (Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth 3.21 % -17.26 % -16.02 % -15.65 % -13.36 %
Y / Y Cash & cash equivalent TTM Growth 129.97 % -26.2 % -29.35 % -70.27 % -73.26 %
Quick Ratio TTM 0.03 0.01 0.01 0.01 0.01
Total Ranking TTM # 4728 # 3249 # 3101 # 3026 # 3769
Seq. Current Liabilities TTM Growth 10.22 % -4.18 % 0.51 % -2.77 % -11.64 %
Seq. Cash & cash equivalent TTM Growth 269.96 % -0.64 % 24.28 % -49.66 % 18.72 %

Quick ratio ranking by company, industry and sector >> Back to CELU Financial Strength Comparisons >> Go to Compare CELU Quick Ratio to its Competitors

On the trailing twelve months basis CELU Cash & cash equivalent more than doubled by 736.72 % in Q4 2025 year on year, faster than Current Liabilities, this led to increase in in Celularity Inc 's Quick Ratio to 0.03, Quick Ratio remained below CELU average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 490 other companies have achieved higher Quick Ratio than Celularity Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 3249 to 4728.

Explain Quick Ratio?
How much Cash & cash equivalents CELU´s has?
What are CELU´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 491
Healthcare Sector # 1003
Within the Market # 4728


trailing twelve months Quick Ratio Statistics
High Average Low
1.78 0.42 0.01
(Mar 31 2022)   (Mar 31 2025)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Redhill Biopharma Ltd   0.21 $ 3.971  Millions$ 19.221  Millions
Polomar Health Services, Inc.  0.21 $ 0.141  Millions$ 0.687  Millions
Quantum Cyber N v   0.20 $ 0.832  Millions$ 4.240  Millions
Adlai Nortye Ltd  0.19 $ 8.056  Millions$ 41.628  Millions
Viatris Inc   0.19 $ 1,388.100  Millions$ 7,420.600  Millions
Igc Pharma Inc   0.18 $ 0.405  Millions$ 2.257  Millions
Citius Oncology Inc  0.16 $ 7.295  Millions$ 44.710  Millions
Bioxytran Inc   0.16 $ 0.510  Millions$ 3.147  Millions
Neurosense Therapeutics Ltd  0.16 $ 0.213  Millions$ 1.358  Millions
Propanc Biopharma Inc   0.15 $ 0.561  Millions$ 3.624  Millions
Pmgc Holdings Inc   0.15 $ 0.572  Millions$ 3.942  Millions
Casi Pharmaceuticals inc   0.14 $ 7.348  Millions$ 51.425  Millions
Cytodyn inc   0.14 $ 11.903  Millions$ 87.018  Millions
Aspire Biopharma Holdings Inc   0.13 $ 1.004  Millions$ 7.593  Millions
Astrazeneca Plc  0.13 $ 6,869.000  Millions$ 52,465.000  Millions
Abbvie Inc   0.12 $ 5,257.000  Millions$ 43,289.000  Millions
Abvc Biopharma Inc   0.12 $ 0.746  Millions$ 6.164  Millions
Cdt Equity Inc   0.12 $ 1.509  Millions$ 12.820  Millions
Lexaria Bioscience Corp   0.11 $ 0.165  Millions$ 1.463  Millions
Citius Pharmaceuticals Inc   0.09 $ 4.252  Millions$ 44.915  Millions
Celularity Inc   0.08 $ 6.175  Millions$ 80.759  Millions
China Pharma Holdings Inc  0.07 $ 0.345  Millions$ 4.701  Millions
Gridai Technologies Corp  0.06 $ 0.900  Millions$ 15.159  Millions
Cv Sciences Inc   0.06 $ 0.278  Millions$ 4.921  Millions
Shuttle Pharmaceuticals Holdings Inc   0.04 $ 0.334  Millions$ 7.967  Millions
Provectus Biopharmaceuticals Inc   0.04 $ 0.251  Millions$ 6.245  Millions
Northwest Biotherapeutics Inc  0.03 $ 3.040  Millions$ 91.700  Millions
Emmaus Life Sciences Inc   0.03 $ 2.127  Millions$ 69.072  Millions
Lunai Bioworks Inc   0.03 $ 0.492  Millions$ 17.267  Millions
Jaguar Health Inc   0.02 $ 0.968  Millions$ 40.654  Millions

Date modified: 2026-06-22T14:32:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.